Medicamen Biotech Ltd — Quarterly Results & Earnings

₹223.30

-4.88%

Profit Growth YoY82.88%Latest quarter

Sales Growth YoY5.43%Latest quarter

Sales CAGR 5Y5.31%5 year compound

Profit CAGR 5Y-11.81%5 year compound

📋

Quarterly Performance

YoY Profit Growth+82.88%

🔥 Exceptional growth

YoY Sales Growth+5.43%

📈 Moderate growth

OPM 5Y Average

Operating profit margin

14.92%

EPS Growth 5Y

-12.51%

Interest Coverage

Higher = safer debt servicing

4.15

ROE

3.39%

ROCE

5.61%

💡

Growth Analysis

Medicamen Biotech Ltd reported YoY profit growth of 82.88% and revenue growth of 5.43% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 5.31% and profits at -11.81% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Medicamen Biotech Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.